You are here: Welcome » Thomas Renz

Thomas Renz

Thomas Renz is an American attorney.

COVID-19 Pandemic

On March 7, 2022, Renz sent a 193 page report detailing evidence that COVID-19 vaccines are harming people.1)

Defense Medical Epidemiology Database (DMED)

  • Renz data summary pulled from DMED for the January 24, 2022 presentation. Renz DMED Summary

Discussions of DMED Controversy

  • Feb 5, 2022 - Update: DoD has 'updated' the numbers in the DMED2)
  • Feb 7, 2022 - David Gorski gives his usual venomous take, but with a few useful links.3)

DMED Whistleblowers

Attorney Tom Renz revealed the names of three Department of Defense (DoD) whistleblowers who attested to the damage caused by Covid-19 vaccines. The names were shared during a Covid-19 roundtable organised by Wisconsin Senator Ron Johnson.

Held on January 25th, 2022, several experts met to discuss the damage caused by vaccines. In attendance was cardiologist Dr. Peter McCullough, Dr. Pierre Kory of the Front Line COVID-19 Critical Care Alliance and mRNA vaccine technology inventor Dr. Robert Malone.

In response to a challenge by Johnson, Renz named the three whistleblowers. Additionally, he presented data that showed a huge increase in serious side effects caused by the jabs.

“We’ve got three whistleblowers who have given me permission at this point to share their names. Lt. Col. Dr. Theresa Long, DO, MPH; Dr. Samuel Sigoloff; and flight surgeon Lt. Col. Dr. Peter Chambers, DO. All three have given me this data; I have declarations from all three [that] this data is under penalty of perjury. We intend to submit this to the courts,” Renz told the senator.

Renz shared his data, showing that post-vaccination miscarriages and cancer cases increased by 300 percent – more than the five-year average – in just a short span of one year. Neurological disorders also increased from 82,000 to 863,000 – which was described as a ten-fold jump – in just a year’s time. Renz added that the neurological issues caused by the jabs would affect pilots.4)

Other Pandemic Controversy

Back to top